RayBiotech Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:RayBiotech Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10827
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
RayBiotech Inc (RayBiotech) is a life science company that provides proteins, antibodies and immunological kits. The company’s product categories include antibody arrays, glycobiology arrays, protein arrays, phosphorylation arrays, elisa, functional assays, antibodies and custom recombinant protein service, among others. It provides services such as testing services, custom services, peptoid services and other services. RayBiotech also offers biostatistics and bioinformatics, molecular biology services, assay development service, consulting service and reversed-phase hplc analysis, among others. The company offers proteomics tools for the advancement of basic and clinical research. RayBiotech is headquartered in Norcross, Georgia, the US.

RayBiotech Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
RayBiotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
RayBiotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
RayBiotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
RayBiotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
RayBiotech Inc, Medical Devices Deals, 2012 to YTD 2018 9
RayBiotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
RayBiotech Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
RayBiotech Enters Into Agreement With Abeome To Provide Monoclonal Antibodies 11
RayBiotech Enters Into Co-Marketing Agreement With Innopsys 12
Licensing Agreements 13
RayBiotech Enters Into Licensing Agreement With Emory University 13
RayBiotech Inc – Key Competitors 14
RayBiotech Inc – Key Employees 15
RayBiotech Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
RayBiotech Inc, Pharmaceuticals & Healthcare, Key Facts 2
RayBiotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
RayBiotech Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
RayBiotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
RayBiotech Inc, Deals By Therapy Area, 2012 to YTD 2018 8
RayBiotech Inc, Medical Devices Deals, 2012 to YTD 2018 9
RayBiotech Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
RayBiotech Enters Into Agreement With Abeome To Provide Monoclonal Antibodies 11
RayBiotech Enters Into Co-Marketing Agreement With Innopsys 12
RayBiotech Enters Into Licensing Agreement With Emory University 13
RayBiotech Inc, Key Competitors 14
RayBiotech Inc, Key Employees 15

List of Figures
RayBiotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
RayBiotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
RayBiotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
RayBiotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
RayBiotech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
RayBiotech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
RayBiotech Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
RayBiotech Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
RayBiotech Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[RayBiotech Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • RedHill Biopharma Ltd (RDHL):企業の財務・戦略的SWOT分析
    RedHill Biopharma Ltd (RDHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • The Lubrizol Corporation-製薬・医療分野:企業M&A・提携分析
    Summary The Lubrizol Corporation (Lubrizol), a subsidiary of Berkshire Hathaway Inc., is a specialty chemical company that produces and supplies technologies to the global transportation, industrial, and consumer markets. Its products and services include engine additives, driveline additives, indus …
  • Cameron International Corporation:石油・ガス:M&Aディール及び事業提携情報
    Summary Cameron International Corporation (Cameron), a subsidiary of Schlumberger Limited specializes in engineering, designing, and manufacturing flow and pressure control technologies for oil and gas industry. The company offers drilling systems, dryaccess deepwater production systems, safety syst …
  • PT Medco Energi Internasional Tbk (MEDC):電力:M&Aディール及び事業提携情報
    Summary PT Medco Energi Internasional Tbk (MedcoEnergi), a subsidiary of Encore Energy Pte. Ltd., is an integrated energy company. It explores for and develops oil and gas fields. The company provides energy related services such as power production, engineering procurement and construction (EPC), o …
  • Norwegian Air Shuttle ASA:戦略・SWOT・企業財務分析
    Norwegian Air Shuttle ASA - Strategy, SWOT and Corporate Finance Report Summary Norwegian Air Shuttle ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Trubnaya Metallurgicheskaya Kompaniya:企業の戦略・SWOT・財務情報
    Trubnaya Metallurgicheskaya Kompaniya - Strategy, SWOT and Corporate Finance Report Summary Trubnaya Metallurgicheskaya Kompaniya - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Stryker Corp (SYK):企業の財務・戦略的SWOT分析
    Stryker Corp (SYK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • South Jersey Industries, Inc. (SJI):電力:M&Aディール及び事業提携情報
    Summary South Jersey Industries, Inc. (SJI) is an energy services holding company that sources and supplies natural gas and electricity. It develops, owns, and operates on-site energy production facilities. The company provides wholesale commodity marketing and fuel management services; and also off …
  • Bristow Group Inc:企業の戦略・SWOT・財務情報
    Bristow Group Inc - Strategy, SWOT and Corporate Finance Report Summary Bristow Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Australian Leaders Fund Limited:企業の戦略・SWOT・財務分析
    Australian Leaders Fund Limited - Strategy, SWOT and Corporate Finance Report Summary Australian Leaders Fund Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Nanovis Inc:医療機器:M&Aディール及び事業提携情報
    Summary Nanovis Inc (Nanovis) is a medical device company that develops and markets tissue regenerating implants for bone and soft tissues. The company offers products such as implant nanosurfaces, implantable scaffolds and cervical plate, lumbar PEEK interbody systems, pedicle screws, injectable bi …
  • BioStar Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary BioStar Pharmaceuticals Inc (BioStar) is a developer, manufacturer and marketer of pharmaceutical and healthcare supplement products for various diseases and conditions. The company offers products such as huangyangning tablets, hyperthyroidism capsules, danshen granule, aoxing oleanolic aci …
  • Teledyne Technologies Incorporated (TDY)-石油・ガス分野:企業M&A・提携分析
    Summary Teledyne Technologies Incorporated (Teledyne) is a provider of instrumentation, digital imaging products and software, aerospace and defense electronics and engineered systems. The company provides electronic subsystems, monitoring instrumentation for marine and environmental applications, h …
  • Compania Minera Autlan SAB de CV:企業の戦略・SWOT・財務情報
    Compania Minera Autlan SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Compania Minera Autlan SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • OGK-2 (OGKB):企業の財務・戦略的SWOT分析
    OGK-2 (OGKB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Shanghai Pudong Development Bank Co., Ltd.:戦略・SWOT・企業財務分析
    Shanghai Pudong Development Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shanghai Pudong Development Bank Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • The Williams Companies, Inc.:企業の戦略・SWOT・財務分析
    The Williams Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Williams Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Atossa Genetics Inc:企業のM&A・事業提携・投資動向
    Atossa Genetics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Atossa Genetics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Sanofi SA:企業のM&A・事業提携・投資動向
    Sanofi SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sanofi SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Regulus Therapeutics Inc (RGLS)-医療機器分野:企業M&A・提携分析
    Summary Regulus Therapeutics Inc (Regulus Therapeutics) is a developer of microRNA based therapeutics. The company provides single stranded oligonucleotides, which are chemically synthesized chains of nucleotides that are mirror images of specific target microRNAs. Its products are used for the ther …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆